Skip to content

Eversense 365 Smart Transmitter Kit (Retail) FG-4001-01-001Recalls & reported problems

Senseonics, Incorporated · Eversense 365 Smart Transmitter Kit contains the Eversense Smart Transmitter, charging accessories, instructions for use, and a wallet card. · Class 2

All models of Eversense CGM (20)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00817491024244), received between Jan 26, 2025 and Feb 13, 2025 — classified as 3 injuries, 1 malfunction.

The most frequently reported specific device problem is “Imprecision” (4 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 2 reportsFeb 2025: 2 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Imprecision4

Patient problems

  • No Clinical Signs, Symptoms or Conditions4
  • Hypoglycemia1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 13, 2025Imprecision; Imprecision

    ON (B)(6) 2025, SENSEONICS WAS MADE AWARE OF AN INCIDENT WHERE USER EXPERIENCED SENSOR INACCURACY. THE CUSTOMER WAS EDUCATED ON THE LAG BETWEEN CGM AND BGM READINGS AND ADVISED ENTER ANY ADDITIONAL CALIBRATIONS REQUESTED BY THE SYSTEM. NO INJURY OR MEDICAL INTERVENTION WAS REPORTED

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21381824 ↗
  • InjuryFeb 7, 2025Imprecision; Imprecision

    SENSEONICS WAS MADE AWARE OF AN INCIDENT WHERE USER REPORTED OF RECEIVING LOW GLUCOSE ALERT ON (B)(6) 2025 WHERE BG WAS 100 MG/DL AND SG WAS 46 MG/DL.AFTER DMS REVIEW,SG WAS 49 MG/DL AT THAT TIME OF EVENT AND NO BG WAS TAKEN.AFTER DMS REVIEW, WE CONFIRMED THAT THE USER RECEIVED A LOW GLUCOSE ALERT AT 08:00 AM.THE USER DIDN'T SEEK FOR MEDICAL TREATMENT AND DIDN'T TAKE ANY ACTIONS TO SOLVE THE EVENT BECAUSE IT WAS A FALSE LOW EVENT, AND HE HAD NO SYMPTOMS.

    Patient problems: Hypoglycemia; No Clinical Signs, Symptoms or Conditions

    MAUDE report 21339145 ↗
  • InjuryJan 26, 2025Imprecision; Imprecision

    ON 27 DECEMBER 2024, SENSEONICS WAS MADE AWARE OF AN INCIDENT WHERE USER REPORTED A LOW GLUCOSE EVENT ON (B)(6) 2024 WHERE SG WAS 45 MG/DL AND BG WAS 120 MG/DL.AFTER DMS REVIEW ON (B)(6) 2024 WHERE SG WAS 43 MG/DL AND BG WAS 120 MG/DL. AFTER DMS REVIEW, WE CONFIRMED THAT THE USER RECEIVED A LOW GLUCOSE ALERT AT 08:10 AM, WHEN THE SG WAS AT 41 MG/DL.THE USER DIDN'T SEEK FOR MEDICAL TREATMENT AND DIDN'T TAKE ANY ACTIONS TO SOLVE THE EVENT BECAUSE HE CONFIRMED THAT IT WAS A FALSE LOW EVENT AND HE HAD NO SYMPTOMS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21238092 ↗
  • InjuryJan 26, 2025Imprecision; Imprecision

    ON 27 DECEMBER 2024,SENSEONICS WAS MADE AWARE OF AN INCIDENT WHERE USER REPORTED A LOW GLUCOSE EVENT ON 22 DECEMBER 2024 WHERE SG WAS 45 MG/DL AND BG WAS 135 MG/DL. AFTER DMS REVIEW ON 27 DECEMBER 2024 WHERE SG WAS 67 MG/DL AND BG WAS 135 MG/DL. AFTER DMS REVIEW, WE CONFIRMED THAT THE USER RECEIVED A LOW GLUCOSE ALERT AT 9:15 AM AS GLUCOSE WAS GOING DOWN, WHEN THE SG WAS AT 61MG/DL. THE USER DIDN'T SEEK FOR MEDICAL TREATMENT AND DIDN'T TAKE ANY ACTIONS TO SOLVE THE EVENT BECAUSE HE CONFIRMED THAT IT WAS A FALSE LOW EVENT, AND HE HAD NO SYMPTOMS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21238073 ↗

Other Integrated Continuous Glucose Monitoring System With Sensor Containing Dexamethasone Acetate devices

All Integrated Continuous Glucose Monitoring System With Sensor Containing Dexamethasone Acetate devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page